Regulatory effects of salt diet on renal renin-angiotensin-aldosterone, and kallikrein-kinin systems

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1975-1980

  Hettinger, Ute ^a   Lukasova, Martina ^a   Lewicka, Sabina ^a   Hilgenfeldt, Ulrich ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood pressure; Bradykinin; Icatibant; Losartan; Normotensive Wistar rats; Spironolactone; Tissue kallikrein expression

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; BRADYKININ; ICATIBANT; KALLIKREIN; KININ; LOSARTAN; MESSENGER RNA; RENIN; SODIUM CHLORIDE; SPIRONOLACTONE; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIET; DOWN REGULATION; GENE EXPRESSION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; RAT STRAIN; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; URINARY EXCRETION; URINE LEVEL; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINE; WISTAR RAT;

ANIMALS; BRADYKININ; KALLIKREIN-KININ SYSTEM; MALE; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHLORIDE, DIETARY; TISSUE KALLIKREINS;

EID: 0036891733     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00163-7     Document Type: Article

References (12)

1. Majima M., Katori M. Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. TIPS. 16:1995;239-246.
2. Figueroa C.D., MacIver A.G., Mackenzie J.C., Bhoola K.D. Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry. 89:1988;437-442.
3. Wang C., Chao C., Chen L.M., Chao L., Chao J. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats. Am. J. Physiol. 271:1996;F824-F830.
4. Wang J., Xiong X., Yang Z., Davis T., Dewey T.J., Chao J.et al. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 23:1994;236-243.
5. Hilgenfeldt U., Linke R., Riester U., König W., Breipohl G. Strategy of measuring bradykinin and kallidin and their concentration in plasma and urine. Anal. Biochem. 288:1995;35-41.
6. Pfaffl M.W. Development and validation of an externally standardised quantitative insulin like growth factor-1 (IGF-1) RT-PCR using LightCycler SYBR® Green I technology. Meuer S., Wittwer C., Nakagawara K. Rapid cycle real time PCR, methods and applications. 2001;281-292 Springer, Heidelberg.
7. Rees D.D., Palmer R.M.J., Shulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
8. 2-receptor knockout mice. Biochem. Biophys. Res. Commun. 224:1996;625-630.
9. Margolius H.S., Chao J., Shimamoto K. New approach to the study of kallikrein in relation to renal function. Gross F., Vogel G. Enzymatic release of vasoactive peptides. 1980;313-322 Raven Press, New York.
10. Bascands J.L., Girolami J.P., Pecher C., Moatti J.P., Suc J.M. Compared effects of a low and high sodium diet on the renal and urinary concentration and activity of kallikrein in normal rats. J. Hypertens. 5:1987;311-315.
11. Barabé J., Huberdeau D., Bernoussi A. Influence of sodium balance on urinary excretion of immunoreactive kinins in rats. Am. J. Physiol. 254:1988;F484-F491.
12. Katori M., Majima M. Role of the renal kallikrein-kinin system in the development of hypertension. Immunopharmacology. 36:1997;237-242.